Evidence map›Paper›PMID 41251788›Full record

ArticleAnalytical and bioanalytical chemistry2026

Magnetic bead-assisted extraction combined with LC-MS/MS for simultaneous quantification of aldosterone and related steroids in human plasma.

Yudong Chu, Qin Su, Ziyuan Huang, Chenyi Yuan, Shazhou Ye, Xueyan Bian

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yudong ChuDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China. chuyudong@foxmail.com.ORCID 0009-0007-7971-0214
Qin SuDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Ziyuan HuangDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Chenyi YuanDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Shazhou YeDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Xueyan BianDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China. fyybianxueyan@nbu.edu.cn.

Funding

the Key Research and Development Program of Ningbo 2023Z177the Nature Science Foundation of Ningbo 2023J160the Research Project of Zhejiang Chinese Medical University 2022FSYYZY16
6 · The paper itself

Abstract

The quantitative analysis of aldosterone and its associated steroid hormone profile including aldosterone (ALD), 18-hydroxycorticosterone (18-OHB), 18-hydroxycortisol (18-OHF), 18-oxocortisol (18-OXOF) and cortisol (F) is critical for the screening, confirmatory testing, and subtype classification of primary aldosteronism (PA). Conventional hormone extraction methods, such as solid-phase extraction and liquid-liquid extraction, are labor-intensive and time-consuming, thereby limiting their applicability and widespread adoption in clinical laboratories. This study developed a novel high-efficiency methodology integrating automated magnetic solid-phase extraction (MSPE) pretreatment with liquid chromatography-tandem mass spectrometry (LC-MS/MS), enabling simultaneous and accurate quantification of ALD, 18-OHB, 18-OHF, 18-OXOF, and F. To ensure the reliability and practicality of the new method, a comprehensive validation of its linearity, accuracy, precision, matrix effect, carryover, stability, and specificity was conducted, and a comparison was made with the traditional solid-phase extraction method. Under optimized conditions, the method demonstrated a satisfactory linear range (18-OHB/18-OHF/18-OXOF: 5-3000 pg/mL, ALD: 0.02-10 ng/mL, F: 2-1000 ng/mL) and extremely low limits of quantification (18-OHB/18-OHF/18-OXOF: 3.75 pg/mL, ALD: 0.02 ng/mL, F: 1.5 ng/mL). Moreover, the recoveries of the five analytes ranged from 90.23% to 104.27%, and the repeatability was between 0.23% and 5.45%. Notably, the magnetic bead-assisted extraction method did not show obvious matrix effects or carryover problems. The target analytes in the processed sample remained stable for 24 h at room temperature and under autosampler conditions. There was a good correlation between this method and traditional solid-phase extraction method. MSPE serves as a critical technological link between complex manual procedures and high-throughput clinical MS. By leveraging its inherent compatibility with automation to streamline workflows and enhance efficiency, it facilitates the broader adoption and application of clinical MS technologies. In conclusion, we have developed a novel method combining magnetic bead extraction with LC-MS/MS that enables simultaneous quantification of ALD, 18-OHB, 18-OHF, 18-OXOF and F for the screening and diagnosis of primary aldosteronism (PA), with potential for further application in clinical research.

Indexed as

AldosteroneSolid Phase ExtractionSteroidsTandem Mass SpectrometryChromatography, LiquidHumansLimit of DetectionLiquid Chromatography-Mass SpectrometryReproducibility of ResultsAldosteroneSteroidsLiquid chromatography-tandem mass spectrometryMagnetic solid-phase extraction (MSPE)Primary aldosteronismSteroids

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.